CTRI/2020/12/029623
Recruiting
未知
Optimizing duration of hospitalization for young infants presenting with any moderate mortality risk sign of possible serious bacterial infection-Study 2 - PSBI RCT 2
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: A499- Bacterial infection, unspecified
- Sponsor
- Centre for Health Research and Development Society for Applied Studies
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients admitted to the study hospitals with relatively higher\-mortality risk signs of CSI at presentation (not feeding well, movement only on stimulation, low body temperature \< 35\.5oC, two or more of the six signs of CSI) will be assessed for eligibility for this study 48 hours after initiation of treatment and considered for inclusion in the study if:
- •1\. Clinically well on day 3 defined as absence of all signs of critical illness (not feeding at all, no movement at all, convulsions) or CSI (not feeding well, movement only when stimulated, low body temperature ( \<35\.5oC), high body temperature (\>\=38oC), severe chest indrawing, fast breathing in \<7 days old), and
- •2\. Laboratory test negative, and
- •3\. Family lives within a catchment area where a follow\-up of up to day 15 can be accomplished.
Exclusion Criteria
- •1\. Weight \<2kg at the time of presentation (if age at screening is less than 10 days) or weight\-for\-age \<\-3z, or
- •2\. Signs of critical illness on admission (no movement at all, unable to feed at all, or convulsions), or
- •3\. Appearance of any high\-mortality risk sign or multiple low\-mortality risk signs in first 24 hours of life, or
- •4\. Hospitalized for any illness in the previous 2 weeks, or
- •5\. Prior use of injectable antibiotics for the same illness, or
- •6\. Previously included in this study or currently included in any other study, or
- •7\. Any other reason to stay in hospital, as decided by the treating physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
How long should young infants less than 2 months of age with moderate-mortality-risk signs of possible serious bacterial infection be hospitalized for?ISRCTN16872570World Health Organization5,250
Not yet recruiting
Not Applicable
A study of the length of stay in the pediatric intensive care unit of patients transferred from ward compared between office hours and non-office hourspatients transferred from ward to PICUPICU, admission timeTCTR20230519001Investigator650
Recruiting
Not Applicable
Optimizing place of treatment for young infants presenting with any low mortality risk sign of possible serious bacterial infectioHealth Condition 1: A499- Bacterial infection, unspecifiedCTRI/2020/12/029776Centre for Health Research and Development Society for Applied Studies
Recruiting
Not Applicable
Clinical evaluation of time to re-hospitalization and renal function of tolvaptan in congestive heart failure patients with volume overload. Prospective randomized controlled trial.congestive heart failureJPRN-UMIN000009810Saiseikai Noe hospital180
Recruiting
Not Applicable
utritional assessment of hospitalized patients aged 90 years and older assessed in our NST from 2008 to 2021all diseasesNST 90years oldJPRN-jRCT1030210611Junro Ishida767